Evidence map›Paper›PMID 32774708›Full record

ArticleAmerican journal of translational research2020

The effect of hepcidin in rats with renal ischemia/reperfusion injury.

Guangliang Xie, Shusu Liu, Qiannan Zhang, Wenli Zhang, Lin Zhu, Yanmin Zhang, Qing Yu

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Guangliang XieDepartment of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine Shanghai 200437, China.
Shusu LiuDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Qiannan ZhangDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Wenli ZhangDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Lin ZhuDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Yanmin ZhangDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Qing YuDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine Shanghai 201620, China.
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study sought to investigate the effectiveness of hepcidin in renal ischemia/reperfusion injury by using a rat model of renal IRI.

methodsIn our study, male Sprague-Dawley rats were divided into a hepcidin-treated group and a control group before establishing the animal models. According to the difference of the modelling methods (renal pedicle occlusion for 45 minutes or not) and renal reperfusion time, the rats were then respectively divided into four subgroups: sham, IRI 4 h, IRI 12 h, and IRI 24 h. After the establishment of the IRI model, the rats were killed to determine renal function, histology, iron metabolism indexes in plasma and tissues, and the expression level of hepcidin and ferroportin-1.

resultsThe results indicated that the levels of serum creatinine, blood urea nitrogen and serum iron, the renal iron content, and the kidney injury score were significantly decreased in the hepcidin group (

conclusionHepcidin has a reno-protective effect in renal IRI by possibly promoting iron intake in the spleen, inhibiting iron absorption and exportation in the duodenum, alleviating the degree of serum iron, and reducing renal iron accumulation in the renal IRI.

Indexed as

ferroportinhepcidiniron metabolism disorderIschemia/reperfusion injuryrat model

Identifiers

PMID32774708
PMCPMC7407705
OpenAlexW3049687247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.